Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI).

[1]  David A Bennett,et al.  Sex differences in the clinical manifestations of Alzheimer disease pathology. , 2005, Archives of general psychiatry.

[2]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[3]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.

[4]  J. Schneider,et al.  Education modifies the relation of AD pathology to level of cognitive function in older persons , 2003, Neurology.

[5]  D. Litaker,et al.  Preoperative risk factors for postoperative delirium. , 2001, General hospital psychiatry.

[6]  W. Weiner,et al.  Transderm-induced psychosis in Parkinson’s disease , 1999, Neurology.

[7]  D. Na,et al.  Normative data on the Korean version of the Boston Naming Test. , 1999, Journal of clinical and experimental neuropsychology.

[8]  A. Ziskind Transdermal scopolamine-induced psychosis. , 1988, Postgraduate medicine.

[9]  R. Rozzini,et al.  Delirium from transdermal scopolamine in an elderly woman. , 1988, JAMA.

[10]  D. Mego,et al.  Transdermal scopolamine as a cause of transient psychosis in two elderly patients. , 1988, Southern medical journal.

[11]  J. A. Wilkinson Side effects of transdermal scopolamine. , 1987, The Journal of emergency medicine.

[12]  F. Sennhauser,et al.  TOXIC PSYCHOSIS FROM TRANSDERMAL SCOPOLAMINE IN A CHILD , 1986, The Lancet.

[13]  K. Rodysill,et al.  Transdermal scopolamine and toxic psychosis. , 1983, Annals of internal medicine.

[14]  J. Camoriano,et al.  Transdermal scopolamine psychosis. , 1982, JAMA.